Bluebird bio Inc

NASDAQ:BLUE   3:59:53 PM EDT
21.23
+0.43 (+2.07%)
Products

Bluebird bio Submits BLA To FDA For Beti-Cel Gene Therapy For Patients With Β-Thalassemia

Published: 09/21/2021 20:58 GMT
Bluebird bio Inc (BLUE) - Bluebird Bio Submits Biologics License Application (bla) to FDA for Betibeglogene Autotemcel (beti-cel) Gene Therapy for Patients With Β-thalassemia Who Require Regular Red Blood Cell Transfusions.